- Advertisement -
- A new clinical trial tested low-dose aspirin in patients with colon and rectal cancer, also referred to as colorectal cancer.
- The researchers wanted to see if taking aspirin daily could help prevent cancer from recurring in people who had a PIK3 genetic mutation.
- In 3 years’ time, aspirin reduced the risk of cancer recurrence in people with the PIK3 mutation by…

